Skip to main content
. Author manuscript; available in PMC: 2017 Aug 30.
Published in final edited form as: Psychiatry Res. 2016 Jun 2;254:3–9. doi: 10.1016/j.pscychresns.2016.06.001

Figure 2.

Figure 2

Estimated marginal means of age-corrected z-scores for clinical high risk participants who endorsed using alcohol at a ‘use without impairment’ severity level (cannabis users, n=100, and cannabis non-users, n=110) for thalamus, hippocampus and amygdala, adjusted for intracranial volume. Significantly smaller hippocampi were seen in CHR cannabis users compared to CHR non-users. Dotted line represents the approximate mean value of healthy controls.